Key training in CMC for small molecules and biologics in Europe
The third session of the regulatory training series took place on 27 May 2025, focusing on “Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe”. Organised by Navarra Health Cluster and Asphalion, the event brought together 22 participants from 7 different organisations to explore the regulatory challenges in biopharmaceutical […]
Training in Pharmacovigilance and Post-Marketing Surveillance: Best Practices and Key Insights from the Sector
On 7 May, the second session of the training capsule series organised by Navarra Health Cluster in collaboration with Asphalion took place. This session focused on post-marketing surveillance activities for medicinal products and medical devices, and was delivered by Laura Eder Azanza, Associate Director of Drug Safety and Deputy EU-QPPV at Asphalion. More than 30 […]
Navarra Health Cluster takes part in the innovation mission organised by CEIN.
Navarra Health Cluster is proud to announce its participation in a mission organised by CEIN, which enabled eight Navarrese startups to attend the prestigious LSX World Congress in London and explore the entrepreneurial ecosystem of Cambridge. During this mission, we had the opportunity to experience first-hand the vibrant and dynamic innovation ecosystem of Cambridge at […]
MIMO Biosciences: One year driving preclinical research against multiple myeloma
MIMO Biosciences, member of Navarra Health Cluster, celebrated its first year of activity in February — a journey already marked by key milestones, including its first capital increase at the end of 2024. Ricardo Pérez, CEO of MIMO Biosciences, introduces the company’s work focused on preclinical-stage drug research for various types of haematological cancers, such […]
Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off
Navarra Health Cluster and its member entity Asphalion launched a new training cycle titled “Regulatory Challenges in Pharmaceutical and Healthcare Innovation” on Tuesday 1 April, with a first session focused on the regulatory hurdles involved in innovation for medical devices, covering procedures in both Europe and the United States. The session, led by Talyta Carteano, […]
Navarra Health Cluster reaches 11% of the regional GDP and grows by 20% in member companies.
The entity’s General Assembly, held this Friday, revealed that the number of member organizations in the last fiscal year was 54. Their combined turnover exceeded €2.65 billion, they employed 18,600 people, and jointly invested more than €120 million in R&D. The cluster, for its part, offered them tailored services such as training workshops and new […]